| 03 May 2024, Friday | |||
| Hall A | Hall B | ||
| IMAGING SESSION Chairs: Dr. Francesco Fici, Dr. Zehra İlke Akyıldız |
|||
| 14:00-14:15 | In Which Patients Should We Use Strain Imaging? Dr. Çetin Alak |
||
| 14:15-14:30 | What Are The Areas Where Cardiac MRI Changes Our Routine Practice? Dr. Ahmet Barutçu |
||
| 14:30-14:45 | Imaging And Beyond In Aortic Diseases Dr. Ebru Özpelit |
||
| 14:45-15:00 | Screening For Pulmonary Hypertension In Connective Tissue Diseases: to Whom and When? Dr. Pınar Talu Eren |
||
| 15:00-15:15 | Discussion | ||
| 15:15-15:30 | Coffee Break | ||
| LIPID AND ATHOSCLEROSIS SESSION Chairs: Dr. Meral Kayıkçıoğlu, Dr. Öner Özdoğan |
|||
| 15:30-15:45 | Has The Concept Of Vulnerable Plaque Changed? Dr. Öner Özdoğan |
||
| 15:45-16:00 | Coronary CT Angiography And CAC In Primary CV Prevention Dr. Özcan Başaran |
||
| 16:00-16:15 | Effect Of Lowering LDL Cholesterol On Atherosclerotic Plaque Dr. Bahadır Kırılmaz |
||
| 16:15-16:30 | Evaluation of Atherosclerotic Plaque In Women Dr. Meral Kayıkçıoğlu |
||
| 16:30-16:45 | Discussion | ||
| 16:45-17:00 | Coffee Break | ||
| OPENING CEREMONY AND RATIONAL DRUG USE IN CV FIELD Konuşmacılar: Dr. M. Remzi Önder, Dr. İstemihan Tengiz |
|||
| 17:00-17:10 | Opening Ceremony | ||
| 17:10-17:30 | Functional Medicine and Rational Drug Use In The Cardiovascular Field Dr. Zülfikar Daneoğlu |
||
| 04 May 2024, Saturday | |||
| Hall A | Hall B | ||
| VALVE DISEASES AND VALVE INTERVENTIONS SESSION Chairs: Dr. Cihan Altın, Dr İsmail Ateş |
DIAGNOSTIC EVALUATION IN HYPERTENSION Chairs: Dr. Filiz Özerkan, Dr. Bahar Boydak |
||
| 09:00-09:15 | From The Forgotten Valve To The Important Valve; Ttricuspid Dr. Hüseyin Bozbaş |
09:00-09:20 | Diagnosis and Classification of Hypertension Dr. Atilla Bitigen |
| 09:15-09:30 | The Importance of Imaging In Mitraklip and Triklip Dr. Zeynettin Kaya |
09:20-09:40 | Evaluation of Target Organ Damage and Total Cardiovascular risk Dr. Emin Alioğlu |
| 09:30-09:45 | Mitraclip, Triclip, Triclave Live In Box With Cases Dr. Cihan Altın , Hüseyin Bozbaş |
09:40-10:00 | Mitraclip, Triclip, Triclave Live in Box With Cases Dr. Kubilay İşsever |
| 09:45-10:00 | TAVI Patient and Valve Selection Dr. Caner Topaloğlu |
||
| 10:00-10:15 | Discussion | 10:00-10:20 | Discussion |
| 10:15-10:30 | Coffee Break | 10:20-10:30 | Coffee Break |
| HEART FAİLURE SESSION AND ARRHYTHMIA SESSION Chairs: Dr. E. İpek Türkoğlu, Dr. Sercan Okutucu |
HEART FAILURE SESSION AND ARRHYTHMIA SESSION Chairs: Dr. Ertuğrul Ercan, Dr. Nezihi Barış |
||
| 10:30-10:45 | Today and Tomorrow of Heart Failure Treatment In The Light of Current Guidelines Dr. Nihan Kahya Eren |
10:30-10:50 | When Start Treatment? Combination Therapy For All? Dr. Roberto Robles |
| 10:45-11:00 | Arrhythmia Meets Heart Failure: Current Approaches In The Treatment of Atrial Fibrillation Dr. Sercan Okutucu |
10:50-11:10 | Therapeutic Strategy in Patients With Diabetes and/or Chronic Kidney Disease Dr. Philippe Van De Borne |
| 11:00-11:15 | Current Approaches To Arrhythmia Treatment. What Has Changed In Clinical Practice? Dr. Emin Evren Özcan |
11:10-11:30 | Arterial Stiffness and Cardiovascular Disease Dr. Thomas Weber |
| 11:15-11:30 | Could Integrative Medicine Have A Place In Cardiology Practice? Dr. E. İpek Türkoğlu |
11:30-11:50 | Discussion |
| 11:30-11:45 | Discussion | ||
| 12:00-13:30 | Lunch | 12:00-14:00 | Lunch |
| NEW STUDIES AND DRUGS SESSION Chairs: Dr. Francesco Fici, Dr. Özge Turgay Yıldırım |
SPECIAL CONDITIONS IN THE TREATMENT OF HYPERTENSION
|
||
| 13:30-13:45 | Colchicine in Cardiovascular Protection Dr. Hatice Solmaz |
||
| 13:45-14:00 | ARNI: Real Life Data Dr. Murat Küçükukur |
||
| 14:00-14:15 | Discussion | ||
|
SATELLITE - NOBEL ILAÇ
|
|||
| 14:15-15:00 | Hypertension and Dyslipidemia: Our Hand is Now Stronger Dr. Hakan Karpuz |
14:00-14:20 | Hypertension and Anxiety Dr. Müge Yaşar |
| 14:20-14:40 | Hypertension and Cancer Dr. Gamze Yeter Aslan |
||
| 14:40-15:00 | Nocturnal Hypertension: Diagnosis and Management Dr. Uğur Önsel Türk |
||
| 15:00-15:20 | Discussion | ||
| 15:00-15:30 | Coffee Break | 15:20-15:30 | Coffee Break |
| INTERVENTIONAL CARDİOLOGY SESSION-I Chair: Dr. Oğuz Yavuzgil |
RESISTANT HYPERTENSION AND FUTURE TREATMENT OPTIONS Chairs: Dr. Mustafa Arıcı, Dr. Osman Akın Serdar |
||
| 15:30-15:45 | PCI In Cardiogenic Shock Dr. İlker Gül |
15:30-15:50 | Resistant Hypertension Dr. Mustafa Arıcı |
| 15:45-16:00 | PCI Management In Thrombosed Lesion Dr. Ufuk Eryılmaz |
15:50-16:10 | Renal Denervation: to Whom and How? Dr. İstemihan Tengiz |
| 16:00-16:15 | PCI In Bypass Patients Dr. Elton Soydan |
16:10-16:30 | What Will The Future Bring? New Guidelines, Gene Therapy, New Drugs? Dr. Guido Grassi |
| 16:15-16:30 | Planning PCI and Antiplatelet Anticoagulant Therapy In Patients With High Bleeding Risk Dr. Hüseyin Dursun |
16:30-16:50 | Discussion |
| 16:30-16:45 | Discussion | 17:00 | Closing Ceremony & Certification |
| INTERVENTIONAL CARDİOLOGY SESSION-II Chair: Dr. Ahmet Taştan |
|||
| 17:00-17:15 | PCI With Physiological Evaluation In Coronary Lesions Dr. Barış Kılıçarslan |
||
| 17:15-17:30 | PCI With Anatomical Evaluation In Coronary Lesions Dr. Volkan Emren |
||
| 17:30-17:45 | PCI and Rotap In Calcific Lesions Dr. Tuncay Kırış |
||
| 17:45-18:00 | Approach To Bifurcation Lesions Dr. Özgür Bayturan |
||
| 18:00-17:15 | Discussion | ||
| 05 May 2024, Sunday | |||
| Hall A | Hall B | ||
| DEBATE SESSION Chairs: Dr. Ertuğrul Ercan, Dr Abdi Sağcan |
ORAL PRESENTATION SESSION Chair: Dr. Remzi Önder |
||
| During AMI, I ………. In The Lesion That is Not Responsible For The Infarction in The Same Session | 10:00 -10:07 | Kalp Yetmezliği Hastasında Sağ Koroner Arterden Sağ Pulmoner Artere Açılan Fistülün Transkatater Koil Embolizasyonla Başarılı Tedavisi Umut Uyan |
|
| 10:00-10:15 | Do Intervene Dr. Deniz Çırgamış |
10:07 - 10:14 | ST-Elevasyonlu Miyokard İnfarktüsü Sonrası Enfarkt Boyutunun Tahmin Edilmesinde Yeni Bir Biyobelirteç |
| 10:15-10:30 | Do Not Intervene Dr. Hümayun Kakar |
10:14 - 10:21 | Obezite ve Kardiyak Aritmiler |
| To The Patient Whose Rhythm Holter Detected Frequent VES……… | 10:21 - 10:28 | Stabil Angina Pektorisli Hastalarda Frontal QRS-T Açısı ile Non-alkolik Yağlı Karaciğer Hastalığı (NAFLD) Fibrozis Skoru Arasındaki İlişki |
|
| 10:30-10:45 | I Recommend Outflow Ablation Dr. Selma Akdeniz Oskay |
10:28 - 10:35 | Serum Karsinoembriyonik Antijen Seviyesi Aortik Sertlik ile ilişkilidir |
| 10:45-11:00 | I Give Medication Dr. Uğur Taşkın |
10:35 - 10:42 | Koroner Anjiyografi Sonrası Kontrasta Bağlı Ensefalopati-Olgu Sunumu |
| I Would Prefer……. Primarily As The Third Antianginal Drug in The Treatment of Chronic Coronary Syndrome | 10:42 - 10:49 | Cerrahi kapak değişiminden kısa süre sonra mekanik kapak trombozu ile ilişkili iskemik inmenin tedavisi |
|
| 11:00-11:15 | Trimetazidine Dr. N. İlker Bayrak |
10:49 - 10:56 | Koroner Anjiyografi Yapılan Stabil Anjina Pektoris Hastalarında Koroner Arter Hastalığı Ciddiyeti ile Non-Alkolik Yağlı Karaciğer Hastalığı Fibrozis Skoru Arasındaki İlişki |
| 11:15-11:30 | Ranolazine Dr. Mustafa Gönençer |
10:56 - 11:03 | Apri Skoru ile KKY Mortalitesi Arasındaki İlişki
|
| I Screen For Myocardial İschemia İn A Diabetic Patient With Exercise Test | 11:03 - 11:10 | Hipertansiyon ile Başvuran Men2a Sendromu Olgusu Deniz Kayış |
|
| 11:30-11:45 | Exercise Test Dr. Taha Okan |
11:10 - 11:17 | COVID-19 ile Hastaneye Yatırılan Hipertansif Hastalarda Antihipertansif İlaçların Uzun Dönem Mortalite Üzerine Etkisi: Tek Merkez Çalışması Selim Aydemir |
| 11:45-12:00 | Coronary CT Angiography Dr. İbrahim Altun |
||